Published in Volume
97, Issue 6 (March 15, 1996)
J Clin Invest. 1996;97(6):1545–1549.
doi:10.1172/JCI118577.
Copyright ©
1996, The American Society for
Clinical Investigation.
Research Article
Potentiation of the immune response in HIV-1+ individuals.
T Schmitz, R Underwood, R Khiroya, W W Bachovchin and B T Huber
Sackler School of Graduate Biomedical Sciences, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
Published March 15, 1996
T cells from HIV-1+ individuals have a defect in mounting an antigen specific response. HIV-1 Tat has been implicated as the causative agent of this immunosuppression. We have previously shown that HIV-1 Tat inhibits antigen specific proliferation of normal T cells in vitro by binding to the accessory molecule CD26, a dipeptidase expressed on the surface of activated T cells. We now demonstrate that the defective in vitro recall antigen response in HIV-1 infected individuals can be restored by the addition of soluble CD26, probably by serving as a decoy receptor for HIV-1 Tat. The restored response is comparable to that of an HIV-1- individual, suggesting that early in HIV infection there is a block in the memory cell response, rather than deletion of these cells.